The Efficacy of Azvudine and Paxlovid in High-risk Patients With COVID-19: A Prospective Randomized Controlled Trial
Clinical trial NCT05642910 · UNKNOWN
Trial details
- NCT number
- NCT05642910
- Sponsor
- Southeast University, China
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-18
- Primary completion
- 2023-01-31
- Enrollment
- 540
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.